1.
|
21 p, 278.8 KB |
Long-term prognosis for 1-year relapse-free survivors of CD34 cell-selected allogeneic hematopoietic stem cell transplantation : a landmark analysis
/
Cho, Christina (Weill Cornell Medical College, New York, NY, 10065, USA) ;
Hsu, Meier (Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA) ;
Barba, Pere (Hospital Universitari Vall d'Hebron) ;
Maloy, Molly A. (Memorial Sloan Kettering Cancer Center) ;
Avecilla, Scott T. (Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA) ;
Barker, Juliet N. (Weill Cornell Medical College, New York, NY, 10065, USA) ;
Castro-Malaspina, Hugo (Weill Cornell Medical College, New York, NY, 10065, USA) ;
Giralt, Sergio A. (Weill Cornell Medical College, New York, NY, 10065, USA) ;
Jakubowski, Ann A. (Weill Cornell Medical College, New York, NY, 10065, USA) ;
Koehne, Guenther (Weill Cornell Medical College, New York, NY, 10065, USA) ;
Meagher, Richard C. (Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA) ;
O'Reilly, Richard J. (Memorial Sloan Kettering Cancer Center) ;
Papadopoulos, Esperanza B. (Weill Cornell Medical College, New York, NY, 10065, USA) ;
Ponce, Doris M. (Weill Cornell Medical College, New York, NY, 10065, USA) ;
Tamari, Roni (Weill Cornell Medical College, New York, NY, 10065, USA) ;
van den Brink, Marcel R. M. (Weill Cornell Medical College, New York, NY, 10065, USA) ;
Young, James W. (The Rockefeller University, New York, NY, 10065, USA) ;
Devlin, Sean M. (Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA) ;
Perales, Miguel-Angel (Weill Cornell Medical College, New York, NY, 10065, USA) ;
Universitat Autònoma de Barcelona
CD34 selection significantly improves GVHD-free survival in allogeneic hematopoietic cell transplantation (allo-HSCT). Specific information regarding long-term prognosis and risk factors for late mortality after CD34-selected allo-HSCT is lacking, however. [...]
2017 - 10.1038/bmt.2017.197
Bone marrow transplantation, Vol. 52 (october 2017) , p. 1629-1636
|
|